Markóczy Zsolt and Sárosi Veronika and Kudaba Iveta and Gálffy Gabriella and Turay Ülkü Yilmaz and Demirkazik Ahmet and Purkalne Gunta and Somfay Attila and Pápai-Székely Zsolt and Rásó Erzsébet and Ostoros Gyula:
Erlotinib as single agent first line treatment in locally advanced or metastatic activating EGFR mutation-positive lung adenocarcinoma (CEETAC): an open-label, non-randomized, multicenter, phase IV clinical trial.
BMC CANCER, 18 (1).
Azonosító: 598-Terjedelem: 7 p.
ISSN 1471-2407
(2018)
Preview |
Text
12885_2018_Article_4283.pdf - Published Version Download (601kB) | Preview |
| Creators: |
|
|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Item Type: | Journal Article | |||||||||||
| Journal or Publication Title: | BMC CANCER | |||||||||||
| Date: | 2018 | |||||||||||
| Volume: | 18 | |||||||||||
| Number: | 1 | |||||||||||
| Page Range: | Azonosító: 598-Terjedelem: 7 p | |||||||||||
| ISSN: | 1471-2407 | |||||||||||
| Faculty/Unit: | Faculty of Medicine | |||||||||||
| Institution: | University of Szeged (2000-) | |||||||||||
| Language: | English | |||||||||||
| MTMT rekordazonosító: | 3381213 | |||||||||||
| DOI azonosító: | https://doi.org/10.1186/s12885-018-4283-z | |||||||||||
| Date Deposited: | 2019. Apr. 23. 11:14 | |||||||||||
| Last Modified: | 2019. Apr. 23. 11:14 | |||||||||||
| URI: | http://publicatio.bibl.u-szeged.hu/id/eprint/15190 |
| Web of Science® Times Cited: 19 | View citing articles in Web of Science® |
Actions (login required)
 |
View Item |
Download Statistics
Download Statistics
